Pancreatic Cancer: Types, Risk Factors, Diagnosis, and Treatment Options

Pancreatic cancer is one of the more challenging cancers to diagnose and treat because symptoms often develop gradually and may remain unnoticed in the early stages. The disease begins in the pancreas, a gland located behind the stomach that plays an essential role in digestion and blood sugar regulation. Although pancreatic cancer is less common than several other cancers, it is considered serious because it is frequently detected at an advanced stage.

Understanding the different types of pancreatic cancer, their risk factors, warning signs, and available treatment options can help patients and families make informed decisions about care. Advances in medical imaging, surgical techniques, and targeted therapies have improved the way pancreatic cancer is diagnosed and managed. This article explains the major types of pancreatic cancer and provides an overview of how the disease is identified and treated.

What is Pancreatic Cancer?

Pancreatic cancer occurs when abnormal cells in the pancreas begin to grow uncontrollably and form a tumour. Over time, these cancerous cells can invade nearby tissues and may spread to other parts of the body if the disease is not detected and treated in its earlier stages.

The condition develops when the normal process that controls cell growth and division becomes disrupted. Instead of growing and dying in a regulated manner, abnormal cells continue to multiply, eventually forming a mass within the pancreas.

Pancreatic cancer is not a single disease but a group of cancers that originate from different types of pancreatic cells. Because of this, the behaviour of the tumour and the treatment approach can vary depending on the specific type of cancer involved. Understanding how the pancreas normally functions can also help explain how pancreatic tumours affect digestion and hormone regulation.

Role of the Pancreas in the Body

To understand how pancreatic cancer affects the body, it is helpful to first understand the normal functions of the pancreas. This organ performs two essential roles that support digestion and metabolic balance.

Digestive Function

The pancreas produces digestive enzymes that are released into the small intestine. These enzymes help break down fats, proteins, and carbohydrates from the food we eat so that the body can absorb essential nutrients. When the pancreas is affected by disease, this digestive process may become less efficient, which can contribute to symptoms such as weight loss, indigestion, or changes in appetite.

Hormonal Function

The pancreas also acts as an endocrine gland by producing hormones that regulate blood sugar levels. The most well-known of these hormones are insulin and glucagon, which work together to maintain stable glucose levels in the bloodstream. When pancreatic cells responsible for hormone production are affected, it can sometimes lead to changes in blood sugar control or the development of diabetes in some patients.

Because the pancreas plays such a central role in digestion and hormone regulation, diseases affecting this organ, including pancreatic cancer, can influence multiple systems within the body.

Risk Factors for Pancreatic Cancer

Pancreatic cancer can develop due to a combination of genetic, lifestyle, and medical factors. While having one or more risk factors does not necessarily mean a person will develop the disease, certain conditions and habits may increase the likelihood of pancreatic cancer over time.

Some of the known risk factors include:

• Smoking: Tobacco use is one of the most significant risk factors for pancreatic cancer. Chemicals in cigarette smoke can damage pancreatic cells and contribute to cancer development.
• Chronic Pancreatitis: Long-standing inflammation of the pancreas can increase the risk of cellular changes that may lead to cancer.
• Diabetes: Long-term diabetes, particularly when newly diagnosed in older adults, has been associated with an increased risk of pancreatic cancer.
• Family History: Individuals with a family history of pancreatic cancer may have a higher risk, especially if multiple close relatives have been affected.
• Obesity: Excess body weight has been linked to a higher risk of several cancers, including pancreatic cancer.
• Age: The likelihood of pancreatic cancer increases with age, and it is more commonly diagnosed in people over the age of 60.

Genetic Mutations and Germline Testing

In some patients, pancreatic cancer may be associated with inherited genetic mutations. Changes in genes such as BRCA1 and BRCA2 can increase the risk of developing pancreatic cancer and may also influence treatment decisions.

For this reason, doctors may recommend germline genetic testing for certain patients, particularly those with a strong family history of cancer. Identifying these mutations can help guide personalised treatment strategies and may allow the use of targeted therapies designed to act on specific genetic alterations.

Warning Signs and Symptoms of Pancreatic Cancer

Pancreatic cancer often develops silently, and symptoms may not appear until the disease has progressed. In the early stages, the signs can be vague and may resemble common digestive problems, which is one reason the condition is frequently diagnosed later.

Some of the symptoms that may be associated with pancreatic cancer include:

• Persistent abdominal pain that may spread to the back
• Unexplained weight loss
• Loss of appetite or feeling full quickly
• Digestive discomfort or bloating
• Fatigue or weakness
• Nausea or changes in bowel habits
• Newly developed diabetes in some patients

Important Warning Sign: Jaundice

One of the more noticeable signs of pancreatic cancer is jaundice, which causes yellowing of the skin and the whites of the eyes. This occurs when a tumour blocks the bile duct, leading to a buildup of bilirubin in the body.

Jaundice may sometimes appear without pain, and this type of painless jaundice should be evaluated promptly by a doctor. Early medical assessment can help identify the underlying cause and allow timely investigation if pancreatic disease is suspected.

How Pancreatic Cancer is Diagnosed

Diagnosing pancreatic cancer usually involves a combination of clinical evaluation, imaging tests, and laboratory investigations. Because the pancreas is located deep within the abdomen, specialised imaging techniques are often required to visualise the organ and detect any abnormal growth.

Doctors may begin with a detailed medical history and physical examination, followed by tests that help confirm the presence of a tumour and determine how far the disease has progressed.

Common diagnostic methods include:

• Imaging tests: CT scans, MRI scans, or abdominal ultrasound are commonly used to identify tumours in the pancreas and assess whether the cancer has spread to nearby structures.
• Endoscopic ultrasound (EUS): This procedure uses a thin flexible tube with an ultrasound probe to obtain detailed images of the pancreas from inside the digestive tract.
• Biopsy: A small sample of tissue may be collected and examined under a microscope to confirm the presence of cancer cells.
• Blood tests: Certain blood markers, such as CA 19-9, may help support the diagnosis and assist in monitoring treatment response.

These investigations help doctors determine the type of pancreatic cancer and its stage, which are essential factors in planning an appropriate treatment strategy.

Types of Pancreatic Cancer

Pancreatic cancer is not a single disease. It can arise from different types of cells within the pancreas, and each type behaves differently in terms of growth, symptoms, and treatment approach. Broadly, pancreatic tumours are classified based on the cells in which the cancer originates. The major types of pancreatic cancer include the following.

Exocrine Pancreatic Cancer

Exocrine pancreatic cancer is the most common type of pancreatic cancer. It begins in the cells that produce digestive enzymes in the pancreas. These enzymes help break down food in the small intestine during digestion.

Within this category, several subtypes may occur:

• Pancreatic adenocarcinoma: This is the most common subtype, accounting for approximately 85% of pancreatic cancer cases. It usually develops in the cells lining the pancreatic ducts that carry digestive enzymes.
• Squamous cell carcinoma: A rare subtype that arises from cells forming the outer lining of pancreatic tissue.
• Giant cell carcinoma: An uncommon and aggressive subtype characterised by large abnormal cells.
• Undifferentiated carcinoma: A rare form in which cancer cells do not resemble normal pancreatic cells and may grow rapidly.

Because exocrine pancreatic cancers tend to develop silently, they are often detected only after the disease has progressed.

Endocrine Pancreatic Cancer (Pancreatic Neuroendocrine Tumours)

Endocrine pancreatic cancers are less common and arise from the hormone-producing cells of the pancreas. These tumours are often referred to as pancreatic neuroendocrine tumours (NETs). Several subtypes exist depending on the hormone produced by the tumour:

• Insulinomas: Develop in cells that produce insulin and may cause episodes of low blood sugar.
• Glucagonomas: Arise from glucagon-producing cells and may lead to high blood sugar levels.
• Gastrinomas: Produce excess gastrin, which can increase stomach acid and lead to ulcers.
• Somatostatinomas: Develop in cells producing somatostatin and may cause digestive symptoms.
• VIPomas: Rare tumours that produce vasoactive intestinal peptide and can cause severe watery diarrhoea.

These tumours may sometimes be detected earlier because the hormones they produce can lead to noticeable symptoms.

Cystic Pancreatic Neoplasms

Cystic pancreatic neoplasms are fluid-filled growths that develop within the pancreas. Not all pancreatic cysts are cancerous, but some types carry a risk of developing into cancer over time.

Common types include:

• Serous cystic neoplasms: Usually benign and often discovered incidentally during imaging tests.
• Mucinous cystic neoplasms: Less common but may have a higher likelihood of becoming cancerous if untreated.
• Intraductal papillary mucinous neoplasms (IPMN): Tumours that grow within the pancreatic ducts and can progress to cancer in some cases.
• Solid pseudopapillary neoplasms: Rare tumours that tend to occur more frequently in younger women and often grow slowly.

Identifying the specific type of pancreatic tumour helps doctors determine the most appropriate management and treatment plan.

Treatment Options for Pancreatic Cancer

The treatment of pancreatic cancer depends on several factors, including the type of tumour, stage of the disease, location of the cancer within the pancreas, and the patient’s overall health. After careful evaluation, doctors develop a personalised treatment plan that may involve one or more treatment approaches.

Common treatment options for pancreatic cancer include the following.

Surgery

Surgery is often recommended when pancreatic cancer is detected at an early stage and the tumour can be safely removed. The goal of surgery is to remove the cancerous tissue along with nearby lymph nodes to reduce the risk of spread.

The Whipple Procedure (Pancreatoduodenectomy)

The Whipple procedure is one of the most common operations performed for pancreatic cancer, particularly when the tumour is located in the head of the pancreas.

During this complex surgery, surgeons remove:

• The head of the pancreas
• Part of the small intestine (duodenum)
• The gallbladder
• A portion of the bile duct

After removal of the affected tissues, the digestive tract is carefully reconstructed to allow normal digestion to continue. The Whipple procedure is a highly specialised surgery that requires significant surgical expertise.

Chemotherapy

Chemotherapy uses anti-cancer medicines to destroy cancer cells or slow their growth. It may be recommended in different stages of treatment.

Chemotherapy may be used:

• Before surgery to shrink the tumour and improve the chances of successful removal
• After surgery to destroy any remaining cancer cells
• For advanced disease to help control tumour growth and relieve symptoms

Radiation Therapy

Radiation therapy uses high-energy beams to target and destroy cancer cells. It may be used alone or combined with chemotherapy.

This treatment may be recommended:

• Along with chemotherapy to improve treatment effectiveness
• When surgery is not possible
• To relieve symptoms caused by tumour growth

Targeted Therapy

Targeted therapy involves medicines designed to act on specific molecules or genetic changes that help cancer cells grow and survive. These treatments may be particularly useful for patients whose tumours carry certain genetic mutations.

Immunotherapy

Immunotherapy is an emerging treatment approach that helps the body’s immune system recognise and attack cancer cells. While it is still being studied for pancreatic cancer, it may be used in selected patients depending on the characteristics of the tumour.

Importance of Early Detection

Pancreatic cancer is often difficult to detect in its early stages because symptoms may be mild or easily mistaken for common digestive problems. However, identifying the disease earlier can significantly influence treatment possibilities and outcomes. When pancreatic tumours are diagnosed at an early stage, patients may have more options for effective treatment.

Early detection is important because it can:

• Expand treatment options: Tumours detected earlier may be suitable for surgical removal, which offers the best chance for long-term control.
• Improve treatment effectiveness: Starting treatment before the disease spreads can improve how well therapies such as chemotherapy or radiation work.
• Reduce complications: Early intervention can help prevent tumour growth from affecting nearby organs and structures.
• Support personalised treatment planning: Modern diagnostic tools, including imaging and molecular testing, allow doctors to tailor treatment strategies to the specific characteristics of the tumour.

Seeking medical evaluation for persistent symptoms, particularly unexplained weight loss, digestive discomfort, or jaundice, can help ensure timely diagnosis and appropriate treatment.

Why Choose RGCIRC for Pancreatic Cancer Treatment

Pancreatic cancer treatment often requires complex decision-making and careful coordination between multiple medical specialties. Effective care depends not only on accurate diagnosis but also on the availability of experienced specialists and advanced treatment technologies. At a dedicated oncology centre, patients benefit from an integrated approach that combines expert evaluation, advanced surgical techniques, and comprehensive supportive care. Here’s why patients choose RGCIRC for pancreatic cancer treatment:

Multidisciplinary Tumour Board Approach

Each pancreatic cancer case is reviewed by a multidisciplinary tumour board consisting of surgical oncologists, medical oncologists, radiation oncologists, radiologists, and pathologists. This collaborative review allows specialists to evaluate imaging findings, biopsy results, and overall patient health together, ensuring that treatment recommendations are carefully tailored to the type and stage of the tumour.

Advanced Diagnostics and Molecular Testing

Accurate diagnosis is essential for planning pancreatic cancer treatment. Modern imaging technologies, endoscopic ultrasound-guided biopsy, and molecular testing help doctors understand tumour characteristics and identify potential genetic mutations. These diagnostic insights support personalised treatment strategies and may guide the use of targeted therapies in selected patients.

Expertise in Complex Pancreatic Cancer Surgery

Pancreatic cancer surgery requires specialised expertise and careful surgical planning. Procedures such as the Whipple procedure (pancreatoduodenectomy) are among the most complex operations in gastrointestinal oncology. Experienced surgical teams perform pancreatic resections using advanced operative techniques. In selected cases, robotic-assisted pancreatic surgery using the da Vinci system may be utilised to enhance surgical precision and support minimally invasive approaches where appropriate.

Precision Radiation Therapy for Inoperable Tumours

For tumours that cannot be surgically removed or are located near critical organs, highly focused radiation techniques may be recommended. CyberKnife-based Stereotactic Body Radiotherapy (SBRT) allows doctors to deliver high-dose radiation to the tumour with sub-millimetre accuracy while minimising exposure to surrounding structures such as the stomach, intestines, and liver. This approach may be used in selected patients with locally advanced pancreatic cancer or as part of a broader treatment strategy.

Comprehensive Cancer Care and Supportive Services

Pancreatic cancer treatment often affects nutrition, digestion, and overall physical strength. In addition to tumour-directed therapies such as surgery, chemotherapy, and radiation therapy, supportive care plays an important role in maintaining quality of life. Nutritional counselling, pain management, rehabilitation services, and psychological support help patients manage treatment-related challenges throughout their care journey.

Final Thoughts

Pancreatic cancer is a complex disease with diverse tumor types, often developing silently in its early stages. However, the landscape of pancreatic oncology has shifted. With breakthroughs in molecular diagnostics, robotic-assisted surgery (da Vinci), and precision radiation like CyberKnife SBRT, patients now have access to more targeted and effective management strategies than ever before.

At RGCIRC, we believe that successful outcomes are built on early detection and a multidisciplinary approach. By combining surgical expertise with personalized medical oncology, we ensure that every treatment plan is as unique as the patient it serves. If you or a loved one are experiencing persistent symptoms, timely evaluation is the most critical step toward recovery. To consult a cancer specialist at RGCIRC, simply call +91-11-47022222.

FAQs

What is the difference between a pancreatic cyst and a pancreatic tumour?

A pancreatic cyst is a fluid-filled sac that develops within the pancreas. Many cysts are benign and may only require monitoring. A pancreatic tumour, however, is a solid growth that may be cancerous and often requires further investigation or treatment.

Is pancreatic cancer hereditary?

Some pancreatic cancers are associated with inherited genetic mutations, such as BRCA1 and BRCA2. Genetic counselling and testing may be recommended for individuals with a strong family history of cancer.

Can pancreatic cancer be detected early?

Early detection can be challenging because symptoms may not appear until the disease progresses. However, imaging tests and medical evaluation can help identify pancreatic tumours when symptoms arise.

How long does pancreatic cancer treatment usually last?

The duration of treatment varies depending on the stage of cancer and the therapies involved. Treatment may include several months of chemotherapy, surgery, radiation therapy, or a combination of these approaches.

Can pancreatic cancer come back after treatment?

Yes, pancreatic cancer can recur after treatment. Regular follow-up visits and monitoring are important to detect any recurrence early and manage it appropriately.

What treatments are available for pancreatic cancer that cannot be operated on?

When surgery is not possible, treatments such as chemotherapy, targeted therapy, or precision radiation techniques like stereotactic body radiotherapy (SBRT) may be used to control tumour growth and manage symptoms.

Where can I find pancreatic cancer treatment near me in Delhi-NCR?

If you are searching for pancreatic cancer treatment near you in Delhi, it is important to consult a specialised cancer centre with experienced surgical oncologists, medical oncologists, and advanced diagnostic facilities. A comprehensive evaluation helps determine the type and stage of pancreatic cancer and the most appropriate treatment plan. If you wish to consult a cancer specialist at RGCIRC, call +91-11-47022222